688046: announcement of Yaokang biology's initial public offering and listing on the science and Innovation Board

Jiangsu Jicui Yaokang Biotechnology Co., Ltd

Initial public offering and listing on the science and Innovation Board

Issuance announcement

Sponsor (lead underwriter):

Scan QR code to view the full text of the announcement

Important tips

Jiangsu Jicui Yaokang Biotechnology Co., Ltd. (hereinafter referred to as "Yaokang biotechnology", "issuer" or "company") is in accordance with the implementation opinions on establishing a science and innovation board and pilot registration system in Shanghai Stock Exchange (CSRC announcement [2019] No. 2) issued by China Securities Regulatory Commission (hereinafter referred to as "CSRC" and "CSRC") Measures for the administration of securities issuance and underwriting (CSRC order [No. 144]) (hereinafter referred to as the "administrative measures"), measures for the administration of the registration of initial public offering of shares on the science and Innovation Board (for Trial Implementation) (CSRC order [No. 174]), Shanghai Stock Exchange (hereinafter referred to as "Shanghai Stock Exchange") promulgated the measures for the implementation of the issuance and underwriting of shares on the science and Innovation Board of Shanghai Stock Exchange (SZF [2021] No. 76) (hereinafter referred to as "the implementation measures"), the guidelines for the application of the Issuance and underwriting rules on the science and Innovation Board of Shanghai Stock Exchange No. 1 - initial public offering of shares (SZF [2021] No. 77) (hereinafter referred to as "the underwriting guidelines") Detailed rules for the implementation of online issuance of initial public offerings in Shanghai market (SZF [2018] No. 40) (hereinafter referred to as "detailed rules for the implementation of online issuance"), detailed rules for the implementation of offline issuance of initial public offerings in Shanghai market (SZF [2018] No. 41) (hereinafter referred to as "detailed rules for the implementation of offline issuance"), The code for underwriting initial public offerings under the registration system issued by the China Securities Association (Zhong Zheng Xie Fa [2021] No. 213) Detailed rules for the administration of offline investors in initial public offerings (zxsf [2018] No. 142), rules for the administration of offline investors in initial public offerings under the registration system and guidelines for the classification, evaluation and management of offline investors in initial public offerings under the registration system (zxsf [2021] No. 212), etc, And the relevant provisions of the Shanghai Stock Exchange on stock issuance and listing rules and the latest operating guidelines, such as initial public offering of shares and listing on the science and innovation board.

Huatai United Securities Co., Ltd. (hereinafter referred to as "Huatai United Securities" or "sponsor (lead underwriter)") serves as the sponsor (lead underwriter) of this offering.

This offering is conducted by a combination of directional placement to strategic investors (hereinafter referred to as "strategic placement"), offline inquiry placement to qualified investors (hereinafter referred to as "offline issuance"), and online pricing issuance to social public investors holding non restricted A-share shares and non restricted depositary receipts market value in Shanghai market (hereinafter referred to as "online issuance"). The strategic placement, preliminary inquiry and online and offline issuance of this offering shall be organized and implemented by the sponsor (lead underwriter) Huatai United Securities. The strategic placement of this offering is carried out at the sponsor (lead underwriter). The preliminary inquiry and offline subscription are carried out through the IPO offline subscription electronic platform of Shanghai Stock Exchange (hereinafter referred to as "offline subscription platform"), and the online issuance is carried out through the trading system of Shanghai Stock Exchange. Please read this announcement carefully. Please refer to the website of Shanghai Stock Exchange (www.sse. Com. CN.) for details of preliminary inquiry and electronic offline issuance The detailed rules for the implementation of offline issuance and other relevant provisions.

Investors can visit the following website( http://www.sse.com.cn./disclosure/listedinfo/listing/ 、 http://www.sse.com.cn./ipo/home/ )Check the full text of the announcement.

Basic information of the issuer

The full name of the company is Jiangsu Jicui Yaokang biological securities, which is abbreviated as Yaokang biological securities

Technology Co., Ltd

Securities code / offline subscription 688046 online subscription code 787046

code

Offline subscription referred to as Yaokang biological online subscription referred to as Yaokang subscription

Basic information of this offering

Offline preliminary inquiry direct

The pricing method determines the issue price, and the number of offline issues (RMB 50 million)

No more cumulative bidding (shares)

inquiry

Total share capital after issuance (10000 shares in total)

Total share capital ratio after 410000000 lines 121951

(%)

High price rejection ratio (%) 1.0056, whichever is lower (yuan / share) 214673

The issue price (yuan / issue price)

Shares) 22.53 exceeds the lower of the four numbers, so, 4.95%

And exceeding range (%)

P / E ratio of issuance (earnings per share in 2020)

Audit deduction and other non recurring valuation indicators (if applicable)

The lower of 138.99 before and after profit and loss is not applicable

Net profit attributable to shareholders of the parent company divided by the total share capital after the issuance)

Industry name and bank research and experimental development industry T-3 static 75.12 times

Industry code (M73) Industry P / E ratio

Determined according to the issue price 5022172 determined according to the issue price 10.04

Committed subscription strategic allocation

Total sales (10000 shares) accounting for the proportion of total sales in this offering

Quantity ratio (%)

Strategic placement callback website 36477828 strategic placement callback website 8500000

Lower issue quantity (10000 shares) upper issue quantity (10000 shares)

Number of proposed offline subscriptions

Maximum amount (10000 shares) (170000 yuan) proposed offline subscription amount of 100.00 yuan

The purchase quantity shall be the lower limit of 100000 shares (10000 shares)

Integer multiple) number of proposed online subscriptions

Maximum amount (10000 shares) (application 0.85 new share placement brokerage commission 0.50

The number of shares purchased shall be 500 shares at the whole rate (%)

(several times) according to the issuing price

Calculated estimated raised capital 11265000 underwriting method balance underwriting

Total amount (10000 yuan)

Important date of this issuance

Offline Subscription Date and starting and ending April 12, 2022 (online subscription date and starting and ending April 12, 2022 (t time day) 9:30-11:30 and 13:00-15:00)

Offline payment date and deadline: April 14, 2022 online payment date and deadline: April 14, 2022 time (T + 2 day) 16:00 time (T + 2 day)

Remarks: 1 "The lower of the four numbers" refers to the lower of the median and weighted average of the remaining quotations of offline investors after excluding the highest quotation, as well as the median and weighted average of the remaining quotations of public offering products, social security funds and pensions.

The issuer and the recommendation institution (lead underwriter) solemnly remind the majority of investors to pay attention to investment risks and invest rationally. They should carefully read this announcement and publish it in Shanghai Securities News and China Securities News on April 11, 2022 (t-1) Special announcement on investment risk of Jiangsu Jicui Yaokang Biotechnology Co., Ltd. in initial public offering and listing on the science and Innovation Board (hereinafter referred to as "special announcement on investment risk") in the securities times and Securities Daily.

This announcement is only a brief description of the issue of shares and does not constitute investment suggestions. Investors who want to know the details of this offering, please read it carefully and publish it on the website of Shanghai Stock Exchange (www.sse. Com. CN.) on March 31, 2022 (T-6) Jiangsu Jicui Yaokang Biotechnology Co., Ltd. IPO and listing on the science and Innovation Board (hereinafter referred to as the "prospectus"). The issuer and the recommendation institution (lead underwriter) hereby remind investors to pay special attention to the chapters of "tips on major matters" and "risk factors" in the prospectus, fully understand the issuer's risk factors, judge its operation status and investment value by themselves, and make investment decisions prudently. The issuer's operating conditions may change due to the influence of politics, economy, industry and operation and management level, and the possible investment risks arising therefrom shall be borne by the investors themselves.

The listing of the shares will be announced separately. 1、 Preliminary inquiry results and pricing

The application of Jiangsu Jicui Yaokang Biotechnology Co., Ltd. for the initial public offering of RMB common shares (A shares) and listing on the science and Innovation Board (hereinafter referred to as "this offering") has been examined and approved by the stock listing committee of the science and Innovation Board of Shanghai Stock Exchange, and has been approved for registration by the CSRC (zjxk [2022] No. 542). The issuer's stock is referred to as "Yaokang biological" for short, and the expanded stock is referred to as "Yaokang biological", with the stock code of "688046". This code is also used for the preliminary inquiry and offline subscription of this issuance, and the online subscription code of this issuance is "787046".

The issuance is carried out in a combination of strategic placement, offline issuance and online issuance.

(I) preliminary inquiry

1. Overall declaration

The initial inquiry period of this offering is 9:30-15:00 on April 7, 2022 (T-3). As of 15:00 on April 7, 2022 (T-3), the sponsor (lead underwriter) has received the preliminary inquiry and quotation information of 9164 placing objects managed by 328 offline investors through the offline subscription platform of Shanghai Stock Exchange. The quotation range is 7.00 yuan / share - 31.13 yuan / share, and the total number of shares to be purchased is 1231008 million. For the specific quotation of the placing object, please refer to the "attached table: statistical table of investor quotation information" of this announcement.

2. Investor verification

According to the conditions for offline investors participating in the preliminary inquiry published in the announcement on the issuance arrangement and preliminary inquiry of Jiangsu Jicui Yaokang Biotechnology Co., Ltd. for initial public offering and listing on the science and Innovation Board (hereinafter referred to as the "announcement on issuance arrangement and preliminary inquiry") published on March 31, 2022 (T-6), after verification by the sponsor (lead underwriter), 11 placing objects managed by 3 offline investors failed to provide review materials or materials as required, but failed to pass the qualification review of the sponsor (lead underwriter); 187 placing objects managed by 53 offline investors belong to the scope of prohibited placing; Eight placing objects managed by three offline investors failed to submit the pricing basis and suggested price or price range before the inquiry; No placing object intends to purchase more than the asset scale or capital scale in the filing materials submitted by it. The quotations of 206 placing objects managed by the above 58 offline investors have been determined to be invalid and eliminated, and the total number of shares to be purchased is 26324 million. For details, please refer to the part marked as "invalid quotation" in the attached table "statistical table of investor quotation information".

After excluding the above invalid quotations, the remaining 8958 placing objects managed by 324 offline investors all meet the conditions of offline investors specified in the announcement on issuance arrangement and preliminary inquiry, with a quotation range of 7.00 yuan / share - 31.13 yuan / share, and the total number of shares to be purchased is 12046840 million.

(II) excluding the highest quotation

1. Elimination

After the issuer and the recommendation institution (lead underwriter) rank the purchase price from high to low according to the inquiry results after excluding the above invalid quotation, and calculate the cumulative total amount of proposed purchase corresponding to each price, the number of proposed purchase according to the placing object in the same purchase price from small to large, the same purchase price and the same number of proposed purchase according to the application time from late to early The same proposed purchase price, the same proposed purchase quantity and the same purchase time (the purchase time is recorded as

- Advertisment -